Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4643277
Max Phase: Preclinical
Molecular Formula: C27H30Cl3F3N6O3S
Molecular Weight: 609.07
Molecule Type: Unknown
Associated Items:
ID: ALA4643277
Max Phase: Preclinical
Molecular Formula: C27H30Cl3F3N6O3S
Molecular Weight: 609.07
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1CCCN1Cc1sc(NC(=O)c2cnc(N3CCC(C(=O)O)CC3)cn2)nc1-c1cc(Cl)cc(C(F)(F)F)c1.Cl.Cl
Standard InChI: InChI=1S/C27H28ClF3N6O3S.2ClH/c1-15-3-2-6-37(15)14-21-23(17-9-18(27(29,30)31)11-19(28)10-17)34-26(41-21)35-24(38)20-12-33-22(13-32-20)36-7-4-16(5-8-36)25(39)40;;/h9-13,15-16H,2-8,14H2,1H3,(H,39,40)(H,34,35,38);2*1H/t15-;;/m1../s1
Standard InChI Key: IXUUOQMYOKRHBI-QCUBGVIVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 609.07 | Molecular Weight (Monoisotopic): 608.1584 | AlogP: 5.81 | #Rotatable Bonds: 7 |
Polar Surface Area: 111.55 | Molecular Species: ACID | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.24 | CX Basic pKa: 8.31 | CX LogP: 2.81 | CX LogD: 2.77 |
Aromatic Rings: 3 | Heavy Atoms: 41 | QED Weighted: 0.35 | Np Likeness Score: -1.94 |
1. Tanaka H, Negoro K, Koike T, Tsukamoto I, Yokoyama K, Maeda J, Inagaki Y, Shimoshige Y, Ino K, Ishizu K, Takahashi T.. (2020) Discovery and structure-activity relationships study of positive allosteric modulators of the M3 muscarinic acetylcholine receptor., 28 (13): [PMID:32386953] [10.1016/j.bmc.2020.115531] |
Source(1):